Efficacy of Cerebrolysin® in Alzheimer’s disease
- 1 January 1994
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- New Piece in Alzheimer's PuzzleScience, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- A Population-Based Study of Dementia in 85-Year-OldsNew England Journal of Medicine, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989Pharmacopsychiatry, 1990
- A multidimensional approach in testing nootropic drug effects (Cerebrolysin®)Archives of Gerontology and Geriatrics, 1990
- Effect of Piracetam on Cerebral Glucose Metabolism in Alzheimer's Disease as Measured by Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1988
- The prevalence of dementia: A quantitative integration of the literatureActa Psychiatrica Scandinavica, 1987
- Is Alzheimer disease caused by lack of nerve growth factor?Annals of Neurology, 1983
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976